Peyton R. Howell - May 22, 2024 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
Director
Signature
/s/ Rachel Malina, Attorney-in-Fact for Peyton R. Howell
Stock symbol
TNDM
Transactions as of
May 22, 2024
Transactions value $
$229,371
Form type
4
Date filed
5/24/2024, 07:22 PM
Previous filing
Aug 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNDM Common Stock Options Exercise $229K +4.43K +36.18% $51.73 16.7K May 24, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM Restricted Stock Unit Award $0 +4.39K $0.00 4.39K May 22, 2024 Common Stock 4.39K Direct F1, F2, F3
transaction TNDM Restricted Stock Unit Options Exercise $0 -4.43K -100% $0.00* 0 May 24, 2024 Common Stock 4.43K Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Awarded on May 22, 2024 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan).
F2 Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
F3 RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan.
F4 Awarded on May 24, 2023 pursuant to the 2023 Plan.